CHIT1 and nasopharyngeal carcinoma: Due to the limitation that chitotriosidase activity can remain in reference ranges, especially in NPC patients affected with late onset forms of the disorder, some novel techniques have been developed recently for biomarkers including oxysterols, lysosphingolipids, bile acid metabolites, and Bis(monoacylglycero)phosphate (BMP/LBPA).